PLEURAN s.r.o. Report issue

For profit Phase 2
Founded: Bratislava Slovakia (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2019
NCT03988257
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

PLEURAN s.r.o.

Active Ingredients

Drugs in Phase 2 Trials (2)

beta-glucans (1 trial)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 2)

Gastroenteritis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2